The Effect of the Allelics of Ser680Asn Polymorphisms of Follicle-Stimulating Hormone Receptor Gene in IVF/ICSI Cycles: a Systematic Review and Meta-analysis.
Controlled ovarian stimulation (COS)
FSHr polymorphisms
Genotyping
IVF/ICSI
Single nucleotide polymorphisms (SNPs)
Journal
Reproductive sciences (Thousand Oaks, Calif.)
ISSN: 1933-7205
Titre abrégé: Reprod Sci
Pays: United States
ID NLM: 101291249
Informations de publication
Date de publication:
02 2023
02 2023
Historique:
received:
06
12
2021
accepted:
02
06
2022
pubmed:
11
6
2022
medline:
9
3
2023
entrez:
10
6
2022
Statut:
ppublish
Résumé
A significant number of single-nucleotide polymorphisms (SNPs) of the follicle-stimulating hormone receptor (FSHr) can modify the response to exogenous FSH administration. A significant diversity in response to controlled ovarian stimulation (COS) in assisted reproductive technologies (ART) according to the type of allelic has been reported. We aimed to evaluate the relation between the Asn680Ser allelics and COS. A total of 4 electronic databases were searched for articles published up to August 2021. Prospective and retrospective comparative studies which reported outcomes after COS in patients who underwent genotyping for the detection of FSHr polymorphisms were considered eligible. A total of 11 studies including 4343 patients with Asn680Ser polymorphisms of the FSHr were included. Patients carrying the Asn/Asn allelic provide elevated E2 on the day of human chorionic gonadotropin (hCG) administration (1549 patients MD 262.39 pg/ml, p = 0.0007), but less transferrable embryos as compared with Ser/Ser genotype (283 patients MD - 0.11 embryos, p = 0.04). Ans/Ser versus Ser/Ser genotypes showed a higher E2 on the day of hCG administration (1799 patients, MD 207.86 pg/ml, p = 0.02). Pregnancy rates were similar in all combination of genotypes. There is currently no strong evidence suggesting that the examination of one gene in relation to genotypes can be effectively used as single tool to improve COS. However, polygenic analysis of different polymorphisms by analyzing the genetic profile of each individual could be useful. Further research is warranted to develop an algorithm that will enable simultaneous analysis of many genes, which combined with hormonal profile could promote treatment individualization.
Identifiants
pubmed: 35680725
doi: 10.1007/s43032-022-00996-x
pii: 10.1007/s43032-022-00996-x
doi:
Substances chimiques
Receptors, FSH
0
Follicle Stimulating Hormone
9002-68-0
Types de publication
Meta-Analysis
Systematic Review
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
428-441Informations de copyright
© 2022. Society for Reproductive Investigation.
Références
Prodromidou A, Anagnostou E, Mavrogianni D, Liokari E, Dimitroulia E, Drakakis P, Loutradis D. Past, present, and future of gonadotropin use in controlled ovarian stimulation during assisted reproductive techniques. Cureus. 2021;13(6):e15663. https://doi.org/10.7759/cureus.15663 .
doi: 10.7759/cureus.15663
pubmed: 34277255
pmcid: 8280946
Tafazoli A, Wołczyński S, Wawrusiewicz-Kurylonek N, Esmaeili SA, Miltyk W. Pharmacogenomic biomarkers of follicle-stimulating hormone receptor malfunction in females with impaired ovarian response-a genetic survey. J Clin Med. 2021;10:2. https://doi.org/10.3390/jcm10020170 .
doi: 10.3390/jcm10020170
Perez Mayorga M, Gromoll J, Behre HM, Gassner C, Nieschlag E, Simoni M. Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype. J Clin Endocrinol Metab. 2000;85(9):3365–9. https://doi.org/10.1210/jcem.85.9.6789 .
doi: 10.1210/jcem.85.9.6789
pubmed: 10999835
Casarini L, Brigante G, Simoni M, Santi D. Clinical applications of gonadotropins in the female: assisted reproduction and beyond. Prog Mol Biol Transl Sci. 2016;143:85–119. https://doi.org/10.1016/bs.pmbts.2016.08.002 .
doi: 10.1016/bs.pmbts.2016.08.002
pubmed: 27697205
de Castro F, Ruiz R, Montoro L, Pérez-Hernández D, Sánchez-Casas Padilla E, Real LM, Ruiz A. Role of follicle-stimulating hormone receptor Ser680Asn polymorphism in the efficacy of follicle-stimulating hormone. Fertil Steril. 2003;80(3):571–6. https://doi.org/10.1016/s0015-0282(03)00795-7 .
doi: 10.1016/s0015-0282(03)00795-7
pubmed: 12969700
Casarini L, Santi D, Marino M. Impact of gene polymorphisms of gonadotropins and their receptors on human reproductive success. Reproduction. 2015;150(6):R175-184. https://doi.org/10.1530/rep-15-0251 .
doi: 10.1530/rep-15-0251
pubmed: 26370242
Mohiyiddeen L, Nardo LG. Single-nucleotide polymorphisms in the FSH receptor gene and ovarian performance: future role in IVF. Hum Fertil (Camb). 2010;13(2):72–8. https://doi.org/10.3109/14647271003632322 .
doi: 10.3109/14647271003632322
pubmed: 20184506
Pabalan N, Trevisan CM, Peluso C, Jarjanazi H, Christofolini DM, Barbosa CP, Bianco B. Evaluating influence of the genotypes in the follicle-stimulating hormone receptor (FSHR) Ser680Asn (rs6166) polymorphism on poor and hyper-responders to ovarian stimulation: a meta-analysis. J Ovarian Res. 2014;7:285. https://doi.org/10.1186/s13048-014-0122-2 .
doi: 10.1186/s13048-014-0122-2
pubmed: 25526787
pmcid: 4279698
Kuijper EA, Blankenstein MA, Luttikhof LJ, Roek SJ, Overbeek A, Hompes PG, Twisk JW, Lambalk CB. Frequency distribution of polymorphisms in the FSH receptor gene in infertility patients of different ethnicity. Reprod Biomed Online. 2011;22(Suppl 1):S60-65. https://doi.org/10.1016/s1472-6483(11)60010-2 .
doi: 10.1016/s1472-6483(11)60010-2
pubmed: 21575851
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hróbjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372: n71. https://doi.org/10.1136/bmj.n71 .
doi: 10.1136/bmj.n71
pubmed: 33782057
pmcid: 8005924
Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J. Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg. 2003;73(9):712–6.
doi: 10.1046/j.1445-2197.2003.02748.x
pubmed: 12956787
DerSimonian R, Kacker R. Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials. 2007;28(2):105–14. https://doi.org/10.1016/j.cct.2006.04.004 .
doi: 10.1016/j.cct.2006.04.004
pubmed: 16807131
Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5:13. https://doi.org/10.1186/1471-2288-5-13 .
doi: 10.1186/1471-2288-5-13
pubmed: 15840177
pmcid: 1097734
Paschalidou C, Anagnostou E, Mavrogianni D, Raouasnte R, Klimis N, Drakakis P, Loutradis D. The effects of follicle-stimulating hormone receptor (FSHR) -29 and Ser680Asn polymorphisms in IVF/ICSI. Horm Mol Biol Clin Investig. 2020;41:2. https://doi.org/10.1515/hmbci-2019-0058 .
doi: 10.1515/hmbci-2019-0058
König TE, van der Lee J, Schats R, Lambalk CB. The relationship between FSH receptor polymorphism status and IVF cycle outcome: a retrospective observational study. Reprod Biomed Online. 2019;39(2):231–40. https://doi.org/10.1016/j.rbmo.2019.05.018 .
doi: 10.1016/j.rbmo.2019.05.018
pubmed: 31279715
García-Jiménez G, Zariñán T, Rodríguez-Valentín R, Mejía-Domínguez NR, Gutiérrez-Sagal R, Hernández-Montes G, Tovar A, Arechavaleta-Velasco F, Canto P, Granados J, Moreno-Macias H, Tusié-Luna T, Pellicer A, Ulloa-Aguirre A. Frequency of the T307A, N680S, and -29G>A single-nucleotide polymorphisms in the follicle-stimulating hormone receptor in Mexican subjects of Hispanic ancestry. Reprod Biol Endocrinol. 2018;16(1):100. https://doi.org/10.1186/s12958-018-0420-4 .
doi: 10.1186/s12958-018-0420-4
pubmed: 30340493
pmcid: 6195735
Allegra A, Marino A, Raimondo S, Maiorana A, Gullo S, Scaglione P, Volpes A, Alessandro R. The carriers of the A/G-G/G allelic combination of the c.2039 A>G and c.-29 G>A FSH receptor polymorphisms retrieve the highest number of oocytes in IVF/ICSI cycles. J Assist Reprod Genet. 2017;34(2):263–73. https://doi.org/10.1007/s10815-016-0835-9 .
doi: 10.1007/s10815-016-0835-9
pubmed: 27817039
Huang X, Li L, Hong L, Zhou W, Shi H, Zhang H, Zhang Z, Sun X, Du J. The Ser680Asn polymorphism in the follicle-stimulating hormone receptor gene is associated with the ovarian response in controlled ovarian hyperstimulation. Clin Endocrinol (Oxf). 2015;82(4):577–83. https://doi.org/10.1111/cen.12573 .
doi: 10.1111/cen.12573
pubmed: 25132286
Trevisan CM, Peluso C, Cordts EB, de Oliveira R, Christofolini DM, Barbosa CP, Bianco B. Ala307Thr and Asn680Ser polymorphisms of FSHR gene in human reproduction outcomes. Cell Physiol Biochem. 2014;34(5):1527–35. https://doi.org/10.1159/000366356 .
doi: 10.1159/000366356
pubmed: 25322982
Yan Y, Gong Z, Zhang L, Li Y, Li X, Zhu L, Sun L. Association of follicle-stimulating hormone receptor polymorphisms with ovarian response in Chinese women: a prospective clinical study. PLoS ONE. 2013;8(10):e78138. https://doi.org/10.1371/journal.pone.0078138 .
doi: 10.1371/journal.pone.0078138
pubmed: 24167601
pmcid: 3805513
Boudjenah R, Molina-Gomes D, Torre A, Bergere M, Bailly M, Boitrelle F, Taieb S, Wainer R, Benahmed M, de Mazancourt P, Selva J, Vialard F. Genetic polymorphisms influence the ovarian response to rFSH stimulation in patients undergoing in vitro fertilization programs with ICSI. PLoS ONE. 2012;7(6):e38700. https://doi.org/10.1371/journal.pone.0038700 .
doi: 10.1371/journal.pone.0038700
pubmed: 22701696
pmcid: 3372493
Sheikhha MH, Eftekhar M, Kalantar SM. Investigating the association between polymorphism of follicle-stimulating hormone receptor gene and ovarian response in controlled ovarian hyperstimulation. J Hum Reprod Sci. 2011;4(2):86–90. https://doi.org/10.4103/0974-1208.86089 .
doi: 10.4103/0974-1208.86089
pubmed: 22064672
pmcid: 3205539
Jun JK, Yoon JS, Ku SY, Choi YM, Hwang KR, Park SY, Lee GH, Lee WD, Kim SH, Kim JG, Moon SY. Follicle-stimulating hormone receptor gene polymorphism and ovarian responses to controlled ovarian hyperstimulation for IVF-ET. J Hum Genet. 2006;51(8):665–70. https://doi.org/10.1007/s10038-006-0005-5 .
doi: 10.1007/s10038-006-0005-5
pubmed: 16871362
Klinkert ER, te Velde ER, Weima S, van Zandvoort PM, Hanssen RG, Nilsson PR, de Jong FH, Looman CW, Broekmans FJ. FSH receptor genotype is associated with pregnancy but not with ovarian response in IVF. Reprod Biomed Online. 2006;13(5):687–95. https://doi.org/10.1016/s1472-6483(10)60660-8 .
doi: 10.1016/s1472-6483(10)60660-8
pubmed: 17169182
Behre HM, Greb RR, Mempel A, Sonntag B, Kiesel L, Kaltwasser P, Seliger E, Röpke F, Gromoll J, Nieschlag E, Simoni M. Significance of a common single nucleotide polymorphism in exon 10 of the follicle-stimulating hormone (FSH) receptor gene for the ovarian response to FSH: a pharmacogenetic approach to controlled ovarian hyperstimulation. Pharmacogenet Genomics. 2005;15(7):451–6. https://doi.org/10.1097/01.fpc.0000167330.92786.5e .
doi: 10.1097/01.fpc.0000167330.92786.5e
pubmed: 15970792
Zilaitiene B, Dirzauskas M, Verkauskiene R, Ostrauskas R, Gromoll J, Nieschlag E. The impact of FSH receptor polymorphism on time-to-pregnancy: a cross-sectional single-centre study. BMC Pregnancy Childbirth. 2018;18(1):272. https://doi.org/10.1186/s12884-018-1910-2 .
doi: 10.1186/s12884-018-1910-2
pubmed: 29954364
pmcid: 6025715
Loutradis D, Patsoula E, Minas V, Koussidis GA, Antsaklis A, Michalas S, Makrigiannakis A. FSH receptor gene polymorphisms have a role for different ovarian response to stimulation in patients entering IVF/ICSI-ET programs. J Assist Reprod Genet. 2006;23(4):177–84. https://doi.org/10.1007/s10815-005-9015-z .
doi: 10.1007/s10815-005-9015-z
pubmed: 16758348
pmcid: 3454958
La Marca A, Papaleo E, Alviggi C, Ruvolo G, De Placido G, Candiani M, Cittadini E, De Michele F, Moriondo V, Catellani V, Volpe A, Simoni M. The combination of genetic variants of the FSHB and FSHR genes affects serum FSH in women of reproductive age. Hum Reprod. 2013;28(5):1369–74. https://doi.org/10.1093/humrep/det061 .
doi: 10.1093/humrep/det061
pubmed: 23504007
Wunsch A, Ahda Y, Banaz-Yaşar F, Sonntag B, Nieschlag E, Simoni M, Gromoll J. Single-nucleotide polymorphisms in the promoter region influence the expression of the human follicle-stimulating hormone receptor. Fertil Steril. 2005;84(2):446–53. https://doi.org/10.1016/j.fertnstert.2005.02.031 .
doi: 10.1016/j.fertnstert.2005.02.031
pubmed: 16084888
Motawi TMK, Rizk SM, Maurice NW, Maged AM, Raslan AN, Sawaf AH. The role of gene polymorphisms and AMH level in prediction of poor ovarian response in Egyptian women undergoing IVF procedure. J Assist Reprod Genet. 2017;34(12):1659–66. https://doi.org/10.1007/s10815-017-1013-4 .
doi: 10.1007/s10815-017-1013-4
pubmed: 28825151
pmcid: 5714814
Ilgaz NS, Aydos OS, Karadag A, Taspinar M, Eryilmaz OG, Sunguroglu A. Impact of follicle-stimulating hormone receptor variants in female infertility. J Assist Reprod Genet. 2015;32(11):1659–68. https://doi.org/10.1007/s10815-015-0572-5 .
doi: 10.1007/s10815-015-0572-5
pubmed: 26404793
pmcid: 4651949
Laven JS, Mulders AG, Suryandari DA, Gromoll J, Nieschlag E, Fauser BC, Simoni M. Follicle-stimulating hormone receptor polymorphisms in women with normogonadotropic anovulatory infertility. Fertil Steril. 2003;80(4):986–92. https://doi.org/10.1016/s0015-0282(03)01115-4 .
doi: 10.1016/s0015-0282(03)01115-4
pubmed: 14556822
Mohiyiddeen L, Newman WG, McBurney H, Mulugeta B, Roberts SA, Nardo LG. Follicle-stimulating hormone receptor gene polymorphisms are not associated with ovarian reserve markers. Fertil Steril. 2012;97(3):677–81. https://doi.org/10.1016/j.fertnstert.2011.12.040 .
doi: 10.1016/j.fertnstert.2011.12.040
pubmed: 22265040
Tănase AE, Nemescu D, Popescu R, Carauleanu A, Mogos RA, Luca A, Onofriescu M. Follicle-stimulating hormone receptor gene polymorphisms of ovarian reserve markers in Romanian population. Exp Ther Med. 2020;20(6):203. https://doi.org/10.3892/etm.2020.9333 .
doi: 10.3892/etm.2020.9333
pubmed: 33123232
pmcid: 7588789
Sudo S, Kudo M, Wada S, Sato O, Hsueh AJ, Fujimoto S. Genetic and functional analyses of polymorphisms in the human FSH receptor gene. Mol Hum Reprod. 2002;8(10):893–9. https://doi.org/10.1093/molehr/8.10.893 .
doi: 10.1093/molehr/8.10.893
pubmed: 12356937
Nenonen HA, Lindgren IA, Prahl AS, Trzybulska D, Kharraziha I, Hultén M, Giwercman YL, Henic E. The N680S variant in the follicle-stimulating hormone receptor gene identifies hyperresponders to controlled ovarian stimulation. Pharmacogenet Genomics. 2019;29(5):114–20. https://doi.org/10.1097/fpc.0000000000000374 .
doi: 10.1097/fpc.0000000000000374
pubmed: 30829738
pmcid: 6587209
Yao Y, Ma CH, Tang HL, Hu YF. Influence of follicle-stimulating hormone receptor (FSHR) Ser680Asn polymorphism on ovarian function and in-vitro fertilization outcome: a meta-analysis. Mol Genet Metab. 2011;103(4):388–93. https://doi.org/10.1016/j.ymgme.2011.04.005 .
doi: 10.1016/j.ymgme.2011.04.005
pubmed: 21546300
Tang H, Yan Y, Wang T, Zhang T, Shi W, Fan R, Yao Y, Zhai S. Effect of follicle-stimulating hormone receptor Asn680Ser polymorphism on the outcomes of controlled ovarian hyperstimulation: an updated meta-analysis of 16 cohort studies. J Assist Reprod Genet. 2015;32(12):1801–10. https://doi.org/10.1007/s10815-015-0600-5 .
doi: 10.1007/s10815-015-0600-5
pubmed: 26481502
pmcid: 4681732
Achrekar SK, Modi DN, Desai SK, Mangoli VS, Mangoli RV, Mahale SD. Poor ovarian response to gonadotrophin stimulation is associated with FSH receptor polymorphism. Reprod Biomed Online. 2009;18(4):509–15. https://doi.org/10.1016/s1472-6483(10)60127-7 .
doi: 10.1016/s1472-6483(10)60127-7
pubmed: 19400992
Anagnostou E, Kafkoutsou A, Mavrogianni D, Domali E, Dimitroulia E, Mathiopoulos D, Drakakis P, Loutradis D (2020) Individual and combined assessment of Ser680Asn FSH receptor and FSHβ -211 G>T gene polymorphisms in ovarian response in IVF/ICSI program. Curr Pharm Biotechnol. https://doi.org/10.2174/1389201021666201029153518